PMDA inspection
Novocol Pharmaceutical of Canada, Inc.
PMDA inspection 5130608007427 · Canada · Suitable
Key facts
| Control number | 5130608007427 |
|---|---|
| Manufacturing site | Novocol Pharmaceutical of Canada, Inc. |
| Location | 25 Wolseley Court Cambridge, Ontario, Canada N1R 6X3 |
| Country | Canada |
| Product type | Pharmaceuticals |
| Application type | New |
| Inspection method | On-Site |
| Inspection month | Jun 1, 2024 |
| Result | Suitable |
| Result notified | Aug 28, 2024 |
| PMDA registration | AG30200075 |
About PMDA GMP inspections (Japan)
Japan's PMDA conducts GMP and QMS inspections of domestic and foreign manufacturing sites that supply the Japanese market.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan